• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物包装对中国间日疟患者治疗依从性的影响。

The effect of drug packaging on patients' compliance with treatment for Plasmodium vivax malaria in China.

作者信息

Qingjun L, Jihui D, Laiyi T, Xiangjun Z, Jun L, Hay A, Shires S, Navaratnam V

机构信息

Health and Epidemic Prevention Station, Changsha, Hunan, China.

出版信息

Bull World Health Organ. 1998;76 Suppl 1(Suppl 1):21-7.

PMID:9763719
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2305576/
Abstract

A study conducted in 1994 showed that the use of blister packs containing antimalarial drugs significantly increased patients' compliance, compared with traditional means of dispensing drugs in a paper envelope. The present study assessed patients' compliance and compared the difference between 3-day chloroquine and 8-day primaquine courses of treatment for vivax malaria. The level of real compliance was determined by making the drugs with phenobarbital, and measuring its level in the blood following treatment. The results show that blister packaging significantly improved patients' compliance (p < 0.001) over traditional means of dispensing antimalarial drugs; there was no difference in treatment compliance between 3-day and 8-day courses when the drugs were in blister packs. However, with ordinary packaging the treatment compliance rate for an 8-day course was significantly less than for a 3-day course (P < 0.05).

摘要

1994年进行的一项研究表明,与用纸质信封传统配药方式相比,使用含抗疟药物的泡罩包装显著提高了患者的依从性。本研究评估了患者的依从性,并比较了间日疟3天氯喹疗程和8天伯氨喹疗程之间的差异。通过在药物中加入苯巴比妥,并在治疗后测量其血液中的水平来确定实际依从性水平。结果显示,与传统抗疟药物配药方式相比,泡罩包装显著提高了患者的依从性(p<0.001);当药物采用泡罩包装时,3天疗程和8天疗程的治疗依从性没有差异。然而,对于普通包装,8天疗程的治疗依从率显著低于3天疗程(P<0.05)。

相似文献

1
The effect of drug packaging on patients' compliance with treatment for Plasmodium vivax malaria in China.药物包装对中国间日疟患者治疗依从性的影响。
Bull World Health Organ. 1998;76 Suppl 1(Suppl 1):21-7.
2
Impact of pre-packaging antimalarial drugs and counselling on compliance with malaria treatment at Port Moresby General Hospital Adult Outpatient Department.
P N G Med J. 2006 Mar-Jun;49(1-2):14-21.
3
Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.氯喹对泰国间日疟的治疗效果评估。
Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):566-9.
4
Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.伯氨喹标准剂量(15毫克/天,共14天)对泰国间日疟患者的治疗效果。
Southeast Asian J Trop Med Public Health. 2001 Dec;32(4):720-6.
5
Directly observed therapy with primaquine to reduce the recurrence rate of plasmodium vivax infection along the Thai-Myanmar border.在泰缅边境采用伯氨喹直接观察治疗法以降低间日疟原虫感染的复发率。
Southeast Asian J Trop Med Public Health. 2011 Jan;42(1):9-18.
6
Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.他非诺喹(WR238605)三剂方案与低剂量伯氨喹预防间日疟原虫疟疾复发的随机试验。
Clin Infect Dis. 2004 Oct 15;39(8):1095-103. doi: 10.1086/424508. Epub 2004 Sep 24.
7
A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India.在印度进行的一项阿奇霉素与氯喹治疗间日疟原虫疟疾的双盲随机研究。
Am J Trop Med Hyg. 2005 Dec;73(6):1108-11.
8
Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine.间日疟:青蒿琥酯加伯氨喹短疗程治疗后的初步观察
Trans R Soc Trop Med Hyg. 2007 Jun;101(6):534-9. doi: 10.1016/j.trstmh.2007.01.003. Epub 2007 Mar 21.
9
Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.青蒿琥酯对泰国间日疟原虫疟疾的治疗效果。
Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):570-4.
10
[Plasmodium vivax malaria: treatment of primary attacks with primaquine, in three different doses, and a fixed dose of chloroquine, Antioquia, Colombia, 2003-2004].[间日疟原虫疟疾:2003 - 2004年在哥伦比亚安蒂奥基亚,用三种不同剂量的伯氨喹和固定剂量的氯喹治疗初发感染]
Biomedica. 2006 Sep;26(3):353-65.

引用本文的文献

1
Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination.用于消除疟疾的新型包衣 15 毫克磷酸萘酚喹制剂的生物等效性。
Malar J. 2024 Jun 5;23(1):176. doi: 10.1186/s12936-024-04947-6.
2
Methods to Assess Adult and Adolescent Patients' Adherence to Antimalarial Treatment: A Systematic Review.评估成人和青少年患者对抗疟治疗依从性的方法:一项系统综述
Front Pharmacol. 2022 Apr 27;13:796027. doi: 10.3389/fphar.2022.796027. eCollection 2022.
3
The effect of blister packaging Iron and Folate on adherence to medication and hemoglobin levels among pregnant women at National Referral Hospital antenatal clinics in a low to middle income country: a Randomised Controlled Trial (The IFAd Trial).低中收入国家国家转诊医院产前诊所中使用泡罩包装铁和叶酸对孕妇服药依从性和血红蛋白水平的影响:一项随机对照试验(IFAd 试验)。
BMC Pregnancy Childbirth. 2022 Mar 3;22(1):179. doi: 10.1186/s12884-022-04507-3.
4
Packaging interventions to increase medication adherence: systematic review and meta-analysis.包装干预措施以提高药物依从性:系统评价与荟萃分析。
Curr Med Res Opin. 2015 Jan;31(1):145-60. doi: 10.1185/03007995.2014.978939. Epub 2014 Nov 4.
5
How patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugs.患者如何接受疟疾治疗:关于抗疟药物依从性的文献系统综述
PLoS One. 2014 Jan 20;9(1):e84555. doi: 10.1371/journal.pone.0084555. eCollection 2014.
6
Intervention to promote patients' adherence to antimalarial medication: a systematic review.促进患者服用抗疟药物依从性的干预措施:系统评价。
Am J Trop Med Hyg. 2014 Jan;90(1):11-9. doi: 10.4269/ajtmh.12-0598. Epub 2013 Oct 28.
7
Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.伯氨喹用于预防接受氯喹治疗的间日疟患者复发。
Cochrane Database Syst Rev. 2013 Oct 26;2013(10):CD004389. doi: 10.1002/14651858.CD004389.pub3.
8
Immunity to malaria in Plasmodium vivax infection: a study in central China.《间日疟原虫感染中的疟疾免疫:中国中部的一项研究》
PLoS One. 2012;7(9):e45971. doi: 10.1371/journal.pone.0045971. Epub 2012 Sep 25.
9
Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal.自我报告数据:评估塞内加尔儿童抗疟联合疗法依从性的主要工具。
Malar J. 2009 Nov 17;8:257. doi: 10.1186/1475-2875-8-257.
10
Adherence of community caretakers of children to pre-packaged antimalarial medicines (HOMAPAK) among internally displaced people in Gulu district, Uganda.乌干达古卢地区境内流离失所者中儿童社区照料者对预包装抗疟药物(HOMAPAK)的依从性
Malar J. 2006 May 15;5:40. doi: 10.1186/1475-2875-5-40.

本文引用的文献

1
Compliance with artesunate and quinine + tetracycline treatment of uncomplicated falciparum malaria in Thailand.泰国对青蒿琥酯及奎宁+四环素治疗非复杂性恶性疟的依从性
Bull World Health Organ. 1998;76 Suppl 1(Suppl 1):59-66.
2
[The radical efficacy of pyronaridine-primaquine combination in tertian malaria].咯萘啶-伯氨喹联合用药治疗间日疟的根治效果
Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1984;2(4):260-2.
3
[Relapses and indirect fluorescent antibody level in vivax malaria patients after chloroquine and chloroquine-primaquine treatment].[氯喹及氯喹-伯氨喹治疗后间日疟患者的复发情况及间接荧光抗体水平]
Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1984;2(4):224-7.